Lexicon Pharmaceuticals Goodwill

Lexicon Pharmaceuticals's goodwill stands at $45M as of September 2026. That compares with $45M in the prior-year period — up 0.0% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Lexicon Pharmaceuticals reported $45M in goodwill versus $45M a year earlier — essentially flat versus a year earlier. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $45M in the prior-year period — up 0.0% year over year. Sustained growth in goodwill can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Lexicon Pharmaceuticals's goodwill evolved across reporting periods, while the comparison chart places LXRX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, goodwill is commonly used to spot outliers. Lexicon Pharmaceuticals's reading of $45M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.